MannKind Corporation cordially invites the press to attend a ceremony onWed Sept 17 in Danbury CT to mark completion of its new facility forproduction of the Technosphere(R) Insulin System. Start time is 10:45 am andthe main ceremony will end at approximately 12 noon.
The events in Danbury are scheduled to include an announcement of theproposed marketing trade name for the Technosphere(R) Insulin System, as wellas a ribbon cutting, luncheon, and tours. Investors, medical and industryprofessionals, scientists, and employees, and local, state, and federalgovernment officials have been invited and are expected to attend andparticipate.
In the Technosphere(R) Insulin System, insulin molecules are loaded ontothe company's proprietary Technosphere(R) particles. These loaded particlesare then aerosolized and inhaled as a dry powder into the deep lung using thecompany's proprietary MedTone(R) inhaler. Because of its rapid absorption intothe bloodstream, Technosphere(R) Insulin has the potential to become thepreferred means for controlling mealtime glucose excursions, the companybelieves.
Only guests with invitations and journalists with valid credentials whohave preregistered will be admitted to the Danbury site. To preregister as ajournalist, please contact Bill Kelly by phone or e-mail as indicated below.
For directions to the Danbury site at One Casper Street, visithttp://harveymalis.com/mannkind.Contact: Bill Kelly HarveyMalis Communications LLC [email protected]
SOURCE MannKind Corporation